Evidence map›Paper›PMID 36635295›Full record

ArticleNature communications2023

Changes in PRC1 activity during interphase modulate lineage transition in pluripotent cells.

Helena G Asenjo, María Alcazar-Fabra, Mencía Espinosa-Martínez, Lourdes Lopez-Onieva, Amador Gallardo, Emilia Dimitrova, Angelika Feldmann, Tomas Pachano, Jordi Martorell-Marugán, Pedro Carmona-Sáez and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Polycomb function in early mouse development.Cell death and differentiation · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 4 countries.

Helena G AsenjoCentre for Genomics and Oncological Research (GENYO), Avenue de la Ilustración 114, 18016, Granada, Spain.ORCID 0000-0003-1904-1606
María Alcazar-FabraCentre for Genomics and Oncological Research (GENYO), Avenue de la Ilustración 114, 18016, Granada, Spain.ORCID 0000-0002-3688-2143
Mencía Espinosa-MartínezCentre for Genomics and Oncological Research (GENYO), Avenue de la Ilustración 114, 18016, Granada, Spain.
Lourdes Lopez-OnievaCentre for Genomics and Oncological Research (GENYO), Avenue de la Ilustración 114, 18016, Granada, Spain.
Amador GallardoCentre for Genomics and Oncological Research (GENYO), Avenue de la Ilustración 114, 18016, Granada, Spain.
Emilia DimitrovaDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID 0000-0001-5669-1240
Angelika FeldmannDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID 0000-0001-7094-8081
Tomas PachanoInstitute of Biomedicine and Biotechnology of Cantabria (IBBTEC), CSIC/Universidad de Cantabria, Santander, Spain.
Jordi Martorell-MarugánCentre for Genomics and Oncological Research (GENYO), Avenue de la Ilustración 114, 18016, Granada, Spain.ORCID 0000-0002-5186-0735
Pedro Carmona-SáezCentre for Genomics and Oncological Research (GENYO), Avenue de la Ilustración 114, 18016, Granada, Spain.
Antonio Sanchez-PozoCentre for Genomics and Oncological Research (GENYO), Avenue de la Ilustración 114, 18016, Granada, Spain.ORCID 0000-0001-8447-0410
Álvaro Rada-IglesiasInstitute of Biomedicine and Biotechnology of Cantabria (IBBTEC), CSIC/Universidad de Cantabria, Santander, Spain.ORCID 0000-0001-7137-1341
Robert J KloseDepartment of Biochemistry, University of Oxford, Oxford, UK.ORCID 0000-0002-8726-7888
David LandeiraCentre for Genomics and Oncological Research (GENYO), Avenue de la Ilustración 114, 18016, Granada, Spain. davidlandeira@ugr.es.ORCID 0000-0002-3267-454X
Universidad de Granada · ESUniversidad de Cantabria · ESUniversity of Oxford · GBGerman Cancer Research Center · DE

Funding

Wellcome Trust
6 · The paper itself

Abstract

The potential of pluripotent cells to respond to developmental cues and trigger cell differentiation is enhanced during the G1 phase of the cell cycle, but the molecular mechanisms involved are poorly understood. Variations in polycomb activity during interphase progression have been hypothesized to regulate the cell-cycle-phase-dependent transcriptional activation of differentiation genes during lineage transition in pluripotent cells. Here, we show that recruitment of Polycomb Repressive Complex 1 (PRC1) and associated molecular functions, ubiquitination of H2AK119 and three-dimensional chromatin interactions, are enhanced during S and G2 phases compared to the G1 phase. In agreement with the accumulation of PRC1 at target promoters upon G1 phase exit, cells in S and G2 phases show firmer transcriptional repression of developmental regulator genes that is drastically perturbed upon genetic ablation of the PRC1 catalytic subunit RING1B. Importantly, depletion of RING1B during retinoic acid stimulation interferes with the preference of mouse embryonic stem cells (mESCs) to induce the transcriptional activation of differentiation genes in G1 phase. We propose that incremental enrolment of polycomb repressive activity during interphase progression reduces the tendency of cells to respond to developmental cues during S and G2 phases, facilitating activation of cell differentiation in the G1 phase of the pluripotent cell cycle.

Indexed as

HistonesPluripotent Stem CellsPolycomb Repressive Complex 1AnimalsCell DifferentiationChromatinInterphaseMicePolycomb-Group ProteinsChromatinHistonesPolycomb-Group ProteinsPolycomb Repressive Complex 1

Identifiers

PMID36635295
PMCPMC9837203
OpenAlexW4315780562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.